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FOREWORD
When Drs. Vaillancourt and Lafond asked me to write this foreword, I was honored to have the opportunity to introduce this eBook.
Despite the improvements in perinatal and neonatal outcomes with the progress in diagnostic, health care and service and treatment, the perinatal morbidity and mortality observed in conjunction with adverse pregnancy outcomes particularly in the developing countries remain an important health problem. A recent study of the American Health Institute suggests that half of all fetal deaths were caused by a complication during pregnancy. Specifically, a placental dysfunction was the cause in 26% of all fetal deaths, infections in the mother were the causes in 14-19% of cases, while in only 10% of cases, fetal malformations or umbilical cord dysfunctions were the cause. This study suggests that any disturbance during pregnancy including the state of the intrauterine environment during critical periods of organogenesis and fetal growth can permanently modify fetal programming; altering the organ structure and work in an epigenetic way.
In tracking healthy pregnancies through research, immense progress was made in understanding the types of disturbances and complications occur in pregnancy. This ongoing research helps to find innovative ways of minimizing these disturbances and complications, dealing with them when they do occur, ultimately leading to healthy pregnancies and healthier infants.
This eBook, while very comprehensive, remains simple in its approach. It aims at providing readers with an update on the current research on pregnancy disorders that affect fetal development and could lead to disability later in childhood and adulthood. The eBook is very well organized in eight chapters written by experts working in the burgeoning area of integrative physiology that attempts to unite nature and nurture.
In conclusion, I am excited about this eBook, not only because of its superbly organized, illustrated and presented content, but also because I anticipate that it will be useful to all those who have an interest in unraveling the mysteries of life. I believe that better management of pregnancy in the present will have long term wide-scale effects on the global health in our society.
Thierry Lacaze-Masmonteil, MD, PhD, FRCPC
Professor of Pediatrics, University of Ottawa Regional Medical Lead-Newborn (Champlain Maternal Newborn Regional Program) Neonatology, Division Head: CHEO-the Ottawa Hospital Children's Hospital of Eastern Ontario 401 Smyth Road, Ottawa, ON, Canada, K1H 8L1
ii PREFACE Adverse pregnancy outcomes are on the rise world-wide, leading to increased perinatal morbidity and mortality. Moreover, pregnancy disorders can lead to disruption in fetal programming. The fetal programming hypothesis suggests that the intrauterine environment during critical periods of organogenesis and tissue growth may permanently alter organ structure and function in an epigenetic manner. Accompanied with this are immense economic and emotional costs. In the course of its research on healthy pregnancy, scientists have made great progress in understanding features of disorders that may occur during pregnancy. These ongoing investigations are important to find ways to treat and prevent these disorders to support women in having healthy pregnancies and babies.
Since 1989, when David Barker showed an inverse relationship between birth weight and mortality due to adult ischemic heart disease, the role of prenatal programming, and by consequence pregnancy disorder, as a determinant of adult diseases has become increasingly clear. While epidemiological evidence for the role of early developmental growth patterns leading to specific adult disease outcomes has continued to strengthen, experimental evidence from animal models has brought new and compelling support for this important determinant of health throughout lifetime.
This eBook aims at providing readers with the latest research on the current state of knowledge related to pregnancy disorders that affect fetal development and possibly fetal programming. This eBook contains eight reviews by experts who are working in this burgeoning area of integrative physiology is an attempts to unite nature and nurture. We trust it to be useful to all of those who have an interest in unraveling the mysteries of life. We believe that better management of pregnancy today will have long term and widescale effects on the health of our society.
INTRODUCTION
The present eBook set of Pregnancy disorders and perinatal outcomes offers its readers a unique opportunity on the current status of knowledge related to maternal habits or disorders that could affect fetal development and lead to disability later in childhood and adulthood. It contains chapters on the role of placenta, hormones, nutrition, diabetes, hypertension, in vitro fertilization, immune systems and epigenetic in pregnancy well-being and perinatal outcomes. Importantly, the eBook integrates both fundamental and clinical medicine as well as molecular and cell biology. This eBook is written with the intent to allow multidisciplinary use and can be recommended to a wide spectrum of readers including students, clinicians (obstetricians, neonatologists, peadiatricians) and basic scientists in the field.
Embryo implantation in the uterus is a critical and intricate event in the development of all mammals and its failure is widely considered to be a challenge to their furtherance. The process of blastocyst implantation requires synchronized interaction between trophoblast cells and the maternal endometrium [1] . Briefly, the events of implantation include: apposition of the blastocyst to the uterine luminal epithelium; adhesion to and penetration through the epithelium and basal lamina; and invasion into the stromal vasculature. This dynamic process involves a complex series of molecular and cellular events that are induced in the pregnant uterus by paracrine and autocrine regulators and also through cell-cell and cell-matrix interactions [2] . The success of implantation depends on achieving the appropriate embryo development to the blastocyst stage and at the same time, the development of an endometrium that is receptive to the embryo. However, embryonic loss in the first trimester occurs in 15-30% of all pregnancies [3] , but the true figure is probably much higher because of the high incidence of pregnancy loss before the clinical detection of pregnancy. Although many losses are likely due to embryonic genetic anomalies, others are due to abnormalities in the uterine environment. In humans, little information is available about the genes whose expression in the endometrium is essential to its interaction with the blastocyst. Ethical and technical issues, such as restrictions in human blastocyst research, the lack of a reliable in vitro implantation model and limited availability of human placental tissue, limits the possibilities of human embryo implantation disorder studies. Thus, most of our current knowledge regarding expression/regulation of genes/proteins during the peri and implantation period has been derived from experimental animals. Rat and mouse models have provided valuable insights into the molecular mechanisms that occur during embryo implantation [4] , however, these models do not necessarily translate to the human because the reproductive physiology of mice and humans is different at different levels [5] .
A wide array of molecules participate in the embryo-uterine interaction, which includes cytokines, adhesion molecules, growth factors and various other molecules [6, 7] . Given the broad array of these molecules, special attention is given here to factors that are released at the implantation site, and particularly, on *Address correspondence to Eric Asselin: Research Group in Molecular Oncology and Endocrinology, Canada Research Chair in Molecular Gyneco-Oncology, Department of Chemistry Biology, University of Quebec at Trois-Rivières, Trois-Rivières, Québec, Canada, G9A 5H7; Tel: 819-376-5011 ext. 3317; Fax: 819-376-5057; E-mail: eric.asselin@uqtr.ca hormones, growth factors and cytokines which are likely to play an important role in regulating trophoblast differentiation and invasion. Discovery of indispensable molecules for successful embryo implantation has provided a great lead in the field of reproductive biology. Despite tremendous research in this field, molecular mechanisms responsible for the process of implantation still need a better understanding. There is a significant knowledge gap in the understanding of this embryo-uterine dialogue, and the in vivo events of implantation. Studies involving the molecular signalling pathways, which regulate uterine receptivity and successful implantation of blastocyst, are of paramount importance. These studies may provide a better understanding of the reasons for implantation failure, which could lead to an improvement in pregnancy rates in humans. In this chapter, we will examine the evidence that failure to develop a receptive endometrium contributes significantly to implantation failure. The purpose of this chapter is to describe the most important players of the embryo-uterine crosstalk in the apposition and adhesion phases which seem to be crucial for successful implantation. The current knowledge as to their expression, regulation, relationships and their involvement in physiological and pathological conditions will also be discussed. In addition, key areas in implantation research will be identified where efforts need to be focused in the future.
ENDOMETRIAL RECEPTIVITY AND IMPLANTATION
Endometrium is termed as receptive, when refractive endometrium is ready to receive blastocyst and allows its attachment with endometrium, which further induces morphological changes in the stromal region leading to decidualization and placentation. The phenomenon of endometrial receptivity was first established in the rat and later validated in other species [8] . Endometrium can exist in different stages like neutral, refractive and receptive. However, for successful implantation timely arrival of viable blastocyst along with receptive endometrium is a pre-requisite. Embryo transfer studies in rodent have established that the endometrium is receptive only for limited time period (for 24 hours) at day 4-5 of pregnancy [9] . However in humans, embryo implantation can only occur in the endometrium during limited period spanning days 20-24 of the menstrual cycle. After which the endometrium becomes refractory to implantation [8] . Embryos entering the uterine cavity before or after the window of receptivity do not attach and implant. This time period is called 'window of implantation', during which the uterine environment is conducive to blastocyst implantation.
Various morphological changes occur in the endometrial epithelial cells during implantation window. One of the changes is the appearance of membrane projections called pinopodes [10, 11] . Pinopodes develop in a progesterone dependent manner and become markedly visible between days 20-21 of the menstrual cycle [11, 12] . The mechanisms of action of pinopodes are still unclear, but their role as biomarkers of endometrial receptivity has been emphasized previously [13] . The presence of pinopodes at the embryoendometrial interface during implantation has been demonstrated, where these pinopodes participate in the adhesion process of the human blastocyst. Furthermore, pinopodes may prevent sweeping off the blastocyst by cilia and helps the withdrawal of uterine fluid thus facilitating adhesion of the blastocyst to molecules of the pinopodes [14, 15] .
Primary step in implantation is the initiation of dialogue between free floating blastocyst and the receptive endometrium ( Fig. 1) . Presence of hormones and cytokines at this stage mediate synchronized endometrial maturation and embryo development [16] . Apposition is the next stage which is identified as an unstable adhesion of the blastocyst to the endometrial surface. During this stage, the trophoblast cells adhere to the receptive luminal epithelium. At this stage the pinopodes, which are micro protrusions from the apical uterine epithelium surface, inter-digitate with microvilli on the apical syncytiotrophoblast surface of the blastocyst [17] This is followed by a stable adhesion or attachment phase where blastocyst anchors to the endometrial basal lamina and stromal extracellular matrix. Paracrine signaling between the embryo and endometrium is responsible for stronger attachment of blastocyst. The first sign of the attachment reaction occurs on the evening of day 4 in mice/rats, or day 20 to 21 in humans, and it coincides with a localized increase in the stromal vascular permeability at the site of blastocyst attachment [18] . The last stage is the invasion process, which involves penetration of the embryo through the luminal epithelium and its basal lamina into the stroma thereby establishing a vascular relationship with the mother, and this activity is mainly controlled by trophoblasts; however the decidua also limits the extent of invasion [19] . In response to this invasion and the presence of constant progesterone stimulation, the endometrial stromal cells and endometrial extracellular matrix undergo decidualization. Which is an essential feature of normal implantation and pregnancy, during this process endometrial stroma transform into a dense cellular matrix known as deciduas [20] . In the process of decidualization, endometrial tissue remodulates, which includes secretory transformation of the uterine glands, influx of specialized uterine natural killer cells, and vascular remodelling [21] . Decidualization of stromal region impedes the movement of trophoblast by creating physical barrier and releasing cytokine in environment which promotes trophoblast attachment rather than invasion. [22, 23] . The timely completion of attachment and decidualization are essential for the viability of the pregnancy.
The establishment of the endometrial transition, which supports embryo implantation, is primarily coordinated by ovarian hormones, progesterone and estrogen, that modulate uterine events in a spatiotemporal manner and that prepare the endometrium to respond to blastocyst signals [24, 25] . In addition to the physical interaction of the embryonic tissue with the uterine cells, this process is undoubtedly influenced by maternal steroid hormones, growth factors and cytokines in paracrine manner thus playing a crucial role in embryonic signaling [7, 26] . The ovarian steroids have a major regulatory role by mobilizing several molecular modulators. Throughout this period, the human endometrium has been prepared to attach the blastocyst because it has acquired an appropriate morphological and functional state initiated by ovarian steroid hormones. Although numerous molecules involved in implantation have been identified in rodents [24, 25] and humans [27] , microarray analysis of human endometrium from the receptive phase has given insight regarding involvement of certain molecules [28, 29] but the molecular mechanisms, regulation of genes, and signal cascades that govern this process of endometrium-blastocyst interaction remain poorly understood. 
Endocrinological Aspects
Progesterone and estrogen are the key hormones responsible for endometrial development. Progesterone is essential for implantation and pregnancy maintenance in all mammals, whereas the requirement for estrogen is species specific [30] . The preimplantation estrogen surge is essential in mice, whereas ovarian estrogen does not play an obligatory role in implantation of primates [31] . Both the epithelial and stromal compartments express progesterone and estrogen receptors and the response depend on the levels of these receptors as well as on the concentration of the hormones themselves. Synchronization between receptor expression and release of hormones is necessary for achieving endometrial receptivity and successful implantation [9, 32] . The uterine effects of estrogen and progesterone are primarily executed by nuclear estrogen and progesterone (ER and PR) receptors [33] . The discovery of ER (ERα and ERβ) and PR (PR-A and PR-B) isoforms and studies of the effects of their selective deletion provide evidence for their Progesterone creates an immunologically conducive milieu for the developing fetus by mediating both the endocrine and immune systems [35] . Uterine natural killer (NK) cells accumulate in the endometrium during estrus and proestrus phases in rodents and during the luteal phase in humans. In addition, NK cells are also evidenced during early pregnancy at sites where fetal trophoblast infiltrates the decidua. Progesterone is the key player in uterine homing of NK cells by promoting NK cell interactions with the endothelium [36] . On the other hand, estradiol induces the expression of α 4 receptors for fibronectin, which is important component of uterine basement membrane [37] . During peri-implantation period, the increased release of estrogen over progesterone promotes proper distribution of integrins in the endometrium, which further facilitate attachment of blastocyst to the receptive endometrium. In future, these hormones and other factors may be used as predictors of endometrial receptivity or embryo quality for the improvement of implantation rates given a better understanding is achieved.
Plethora of other endocrinological factors is known to be involved in the process of pregnancy apart from progesterone and estrogen [38] . It is well documented in the literature that prostaglandins (PGs) play an important role in reproductive processes, including ovulation, implantation, and menstruation [39, 40] . The rate-limiting step in PG biosynthesis is catalyzed by cytosolic phospholipase A 2 (PLA 2 ) enzymes, which release arachidonic acid (AA) from membrane phospholipids [41] as shown in Fig. 2 . Cyclooxygenases (COX-1 and COX-2) mediate the conversion of arachidonic acid into prostaglandinH2 (PGH2), which is then converted into various PGs by specific synthase. Earlier study from our laboratory has shown that PGD synthase (PGDS) and prostacyclin synthase (PGIS) are present in the rat uterus during pregnancy and high levels could be seen at the early stage of pregnancy. The expression of various PG synthases could be regulated by steroids and that the endometrium could be a significant source of PGD 2 and PGI 2 at specific times during pregnancy [42] . Extensive research in the field of pregnancy highlighted and established the vital role of PGs in the implantation process. Achache et al. [43] have reported that patients with recurrent pregnancy failure were shown to have very low levels of cPLA 2α and COX-2, possibly reducing further PG synthesis, which could be responsible for implantation failure. Previous study by Song et al. [44] in female mice lacking cPLA 2 or COX-2 enzymes has also established the central role of PGs in implantation. Mice lacking either of these enzymes lead to absence of PG synthesis, which results in improper embryo implantation. Moreover, it had also been studied that cPLA 2 knockout mice experience pregnancy failure. Lysophosphatidic acid (LPA), a lipid-derived G-protein-coupled receptor (GPCR) agonist plays crucial roles in a wide array of processes, including cell proliferation, survival and differentiation, invasion and cell-cell interaction. LPA 3 -deficient mice was markedly similar to those reported for rats and mice treated with the PG-synthesis inhibitor, indomethacin [45] , and for mice deficient in cPLA 2α [44] . Modulation of PG synthesis before or during the time of implantation can be fatal for implantation by reducing the number of implantation sites with reduced decidual tissue, which can further lead to delayed implantation.
COX-1 is functions as a constitutive enzyme whereas COX-2 is highly inducible by diverse stimuli including mitogens, cytokines, growth factor and tumor promoters. COX-2 enzymes is known to regulate inflammation, differentiation and angiogenesis [46] . Recent study from our lab evidenced that COX-1 and COX-2 proteins are present during different stages of pregnancy in rat endometrium, indicating important role of these proteins in the process of pregnancy and expression of these cyclooxygenases are controlled by sex hormones [47] . The unique expression pattern of COX-1 and COX-2 genes in preimplantation mouse uterus suggests an important role for PGs in embryo implantation. This expression pattern suggests that COX-2 expression during the attachment reaction is critical for implantation [48] . COX-2 deficient mice were found to exhibit multiple reproductive failures, which were not observed in the case of COX-1 deficient mice. Furthermore, up regulation of COX-2 and prostacyclin (PGI 2 ) synthesis were found to be essential for implantation in the mouse [49] . Previous studies in rodents suggest that the enzymes responsible for prostaglandins (PGs) synthesis i.e., COX-1 and COX-2 show cyclic changes in their expression pattern [47, 48, 50] . These PGs further affect the process of implantation by changing the vascular permeability of the uterus [51] . PGs are also speculated to play an important role in maintaining implantation window, as delayed implantation of blastocyst could generate ripple effect by crowding embryo near cervix, abnormal placentation and fetal resorption. However, PGs supplementation can partially restore a normal phenotype. There are concerns that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, aspirin, indomethacin and celecoxib may interfere with implantation of embryo. NSAIDs are considered to be the inhibitors of COX-2 and prostaglandin biosynthesis in most organ, including reproductive system, which could lead to abnormal implantation that predisposes an embryo to peri-implantation loss [52] . Previously, Sookvanichsilp and Pulbtur (2002) have also demonstrated that the administration of indomethacin and celecoxib to rats significantly reduced the uterine decidualization. The above mentioned studies suggest that COX-derived PGs are important factors at the critical time of implantation for subsequent post-implantation development.
Cell Adhesion Molecules
Integrins
The cell adhesion molecule (CAM) family is composed of four members known as integrins, cadherins, selectins and immunoglobulins. These surface ligands, usually glycoproteins, mediate cell-to-cell adhesion. Integrins are among the best characterized markers of endometrial receptivity [53] .
Integrins are a family of transmembrane glycoproteins, formed by the association of two different, noncovalently linked, α and β subunits. Heterodimers of α and β integrins serve as receptors for extra cellular matrix (ECM) ligands such as collagen, laminin and fibronectin, as well as transducing signals from soluble ligands such as osteopontin [54] . To date, eighteen α and eight β chains have been identified in mammals. They can combine into 24 different integrin heterodimers having different functional significances [55] . A large variety of integrins have been described within the luminal and glandular endometrial epithelium [6, 56] . In spite of presence of various integrins during menstrual cycle differential expression pattern were observed for a few intergrin molecules. However, majority of the integrin molecules show constitutive expression throughout this period. [6] . Given their high expression during mid-luteal phase, some intergrins could play a crucial role as markers of the window of implantation [57] . α1β1, α4β1 and αVβ3 integrins are shown to be expressed in cyclic manner in human endometrium on days 20-24 of the human menstrual. According to a timed expression correlating with embryo attachment, the αVβ3 and the α4β1 integrins are considered markers of uterine receptivity [58, 59] . αVβ3 has been shown to be highly expressed at the time of embryo attachment, and aberrant expression of αVβ3 is associated with infertility [60, 61] . Women with recurrent miscarriages were found to have a lower concentration of α4β1 and α5β1 integrins in the stroma during the implantation window, than women with unexplained infertility [62] . In female mice lacking a functional integrin β1 gene, embryos develop normally to the blastocyst stage but fail to implant properly and die [63] . In knockout studies, no other integrins were found to be involved in implantation defects [7] , except α V β3, whose inactivation by echistatin significantly reduced implantation sites in mice [64] . All these reports indicates functional redundancy of several integrins in the process of implantation [65] . Moreover, α V β3 integrin as well as its ligand osteopontin was positively detected by immunohistochemistry on the endometrial luminal epithelial surface, which first interacts with the trophoblast [66] . Therefore, αVβ3 has been proposed as a potential receptor for embryonic attachment [32] .
Human trophoblast is known to express integrins at the time of implantation during implantation period [67] . Trophoblastic receptors for ECM (essentially, integrins α1β1 and α5β1) increase in concert with the differentiation of human cytotrophoblast cells to invasive extravillous phenotype [68] . The integrins present both on the uterine epithelium (osteopontin) and on trophoblast surface (oncofetal fibronectin) have affinity for specific ECM components. Incomplete maternal recognition of embryo was found in the absence of α4β1 integrin due to its inability to recognize fibronection on the surface of trophoblast [69] . This provides the possibility of a sandwich model of embryonic adhesion. Aberrant expression of integrins has been observed in the endometrium of women with reproductive failure [69] .
Selectins
Selectins are glycoproteins which also belong to the CAM family. They include P-selectin, L-selectin and Eselectin [70] . Human L-selectin is a transmembrane protein with highly glycosylated extracellular domain and a small cytoplasmic tail [71] . The selectin adhesion system is well established at the maternal-fetal interface. At the time of endometrial receptivity, L-selectin has been found to be highly up regulated and present on the entire embryonic surface [72] . Previous studies in literature suggest that the interaction between L-selectin, expressed by trophoblast cells, and its oligosaccharide ligands, expressed by the endometrium, may constitute the initial step in the implantation process [73] . L-selectin has been found to initiate a signaling cascade that facilitates strong embryo attachment with the uterine epithelium which further helps the embryo in establishing contacts with maternal vasculature at the time of placenta formation [73] . In conclusion, very little is known about the involvement of selectins in embryo implantation.
Cadherins
Cadherins constitute a group of glycoproteins responsible for the calcium-dependent cell-to-cell adhesion mechanism. Amongst the various subclasses (E-, P-, and N-cadherins) of cadherins, E-cadherin represents the most studied subclass. E-cadherin is a cell surface transmembrane glycoprotein, which belongs to the family of calcium-dependent cell adhesion molecules (CAMs) that mediates cell-cell adhesion through homeotypic binding. E-cadherin is located in the adherents junctions that are specialized regions on the lateral side of the epithelial plasma membrane and is believed to be critical for the establishment and maintenance of these junctions in epithelial cells [74, 75] . Previous reports indicated that targeted mutations in the E-cadherin gene could result in defective pre-implantation development of the [76] . The role of Ecadherin in human embryo implantation is not known, but based on its expression pattern; it is suspected that might be of important during this process.
Mucins
Mucins are glycoylated molecules found on a great number of tissues, including the endometrial epithelial cells [77] . Enzymatic actions on the cellular surface are impeded by mucins, which also prevent cell-cell and cell-extracellular matrix adhesion. At least 19 human mucin genes have been distinguished by cDNA cloning but MUC-1 and MUC-4 are the two major mucins present in human endometrium both in proliferative and secretory phases [78, 79] . They are believed to be a barrier to trophoblast invasiveness, by controlling accessibility of integrin receptors to their ligands [80] . MUC1 increases from the proliferative to the secretory phase in endometrial tissue and then decreases in the late secretory phase [81] . It has been suggested that progesterone along with estrogen up-regulates MUC1 at the receptive endometrium [81] . This up regulation of MUC1 during apposition phase [82] prevents the attachment of blastocyst for first three days of blastocyst entry in uterus [83] . However, MUC1 was found to be down-regulated in the receptive endometrium before implantation suggesting anti-adhesive role during apposition [84, 85] . High levels of progesterone down-regulates MUC1 expression which further improves embryo-epithelial interactions by unmasking CAMs on the endometrial surface [86] . Hence, MUC1 inhibits implantation and its down-regulation could contribute to the achievement of endometrial receptivity. Unlike other species, human endometrial MUC1 was found to be up-regulated during the peri-implantation period [87, 88] . It was suggested that humans require a locally acting mechanism for the removal of the MUC1 barrier to the implanting embryo [89] . Reduced levels of endometrial MUC1 were reported in women with recurrent pregnancy loss. [90] . This suggests that primary infertility due to implantation failure might be associated with a polymorphism in the MUC1 variable number of tandem repeat (VNTR), resulting in a protein with a substantial reduction in the number of O-glycosylation sites. However, MUC4 VNTR polymorphism did not show any statistically significant difference between the spontaneous fertile and infertile population with or without unexplained embryo implantation failures.
Molecular Basis of Implantation
Transcription Factors
Implantation is governed by molecular mechanism mediated by homeobox (HOX) genes. The protein products of HOX genes belong to a class of proteins known as transcription factors, all of which are capable of binding to DNA, thereby regulating the transcription of genes [91] . The target of HOX genes promotes cell division, cell adhesion, apoptosis, and cell migration. HOX genes are arranged in four clusters (HOXA, HOXB, HOXC, HOXD) which are located on four separate chromosomes and each cluster houses between nine and 11 genes. The expression of HOX genes has been shown to regulate the growth and development of the human endometrium, which varies in response to hormones during the menstrual cycle, with significant up-regulation in the mid-secretory phase, coinciding with the implantation window [92] . Amongst all the homeobox genes, it has been suggested that HOXA-10 and HOXA-11, were shown to be important for implantation, because mice with mutations in these genes fail to achieve normal implantation [93, 94] . HOXA-10 and HOXA-11 are expressed in endometrial cells of mice and in the endometrial glands and stroma of the human uterus during the menstrual cycle [92, 95, 96] . Knock-down of HOXA-10 expression using siRNA mediated approach in mouse models prevents implantation. In addition, patients with endometriosis, fibroids, and polycystic ovary syndrome were found to have very low levels of HOXA-10 expression. Moreover, HOXA-10 has been demonstrated to regulate the expression of β3 integrin as well as several other genes involved in endometrial receptivity. Uterine stromal cells in HOXA-10 deficient female mice show reduced proliferation in response to progesterone, leading to decidualization defects [97, 98] . Furthermore, HOXA-10 expression plays an essential role in pinopod development. Indeed, blocking HOXA-10 expression dramatically decreases the number of pinopodes [99] . On the other hand, HOXA-11deficient mice are infertile due to endometrial implantation defects. HOXA11 -/ -mice have reduced expression of leukemia inhibitory factor (LIF) [94] . The importance of LIF in embryo implantation will be discussed in the next section. In addition, HOXA-10 and HOXA-11 have been found to be essential for fertility in mice [94] . Previous studies evidenced that female mice that are homozygous mutants of either of these genes are infertile due to the endometrial factors [100, 101] . Thus, a gene therapy approach that may involve the manipulation of the expression of HOX genes could have a role in the enhancement of endometrial receptivity and implantation.
Cytokines
Cytokines and growth factors are cell-derived polypeptides and proteins which bind to specific cell surface receptor kinases leading to the activation of signaling cascades involved in the regulation of embryomaternal interactions. By autocrine, paracrine and endocrine mechanisms, cytokines are believed to regulate various cellular functions like proliferation, differentiation and apoptosis [27, 102] . As regards of their role in implantation, cytokines secreted by uterus and the embryo promotes endometrial receptivity by regulating the levels of adhesion and anti-adhesion proteins [7] . Disturbances in the normal expression and action of these cytokines result in an absolute or partial failure of implantation and abnormal placental formation in mice and human [103] .
Leukemia Inhibitory Factor (LIF)
LIF, which is a member of IL-6 type cytokine family, is a glycoprotein [104] . It is secreted from the uterus and is regarded as an important factor in embryo implantation. The pleiotropic effects of LIF are accomplished by binding to heterodimeric LIF receptor (LIFR), which consists of two transmembrane proteins, LIFR and gp130. The up-regulation of LIF also requires the action of the homeobox gene Hmx3 [4] . The LIFR activates several signaling pathways in diverse cells types, including the Jak/STAT, MAPK, and PI3-kinase (PIPK) pathways [105] . Deletion of the genes for LIF, Hmx3 or a mutant gp130 deficient in STAT3 signalling all result in the failure of embryo attachment due to a failure of the epithelium to respond to the embryo [4, 106, 107] . In the endometrium of a fertile woman, LIF mRNA and protein are expressed throughout the menstrual cycle with a striking increase in the mid-and late secretory phase and during early pregnancy [108, 109] . LIF knockout female mice lacking a functional LIF gene are fertile, but the blastocysts fail to implant, even though they are viable and can implant when transferred to wild-type recipients. However, when LIF was injected into LIF knockout mice, they showed normal implantation [106, 110] . Previous studies showed that infertility could be associated with lower levels of LIF in endometrium [111, 112] . Furthermore, Giess et al. (1999) demonstrated that mutation in LIF genes might led to decreased activity of LIF in the endometrium and cause implantation failure. Embryos lacking either LIFR or gp130 develop to the blastocyst stage and implant normally but die during the perinatal period [113] . Thus LIF may signal to both embryonic and uterine cells during implantation [114] . Taken together, there is a strong evidence for an important role of LIF in both rodents and primate implantation. In view of the important role of LIF in implantation, administration of such r-hLIF could be valuable in future studies.
Interleukin-6 (IL-6)
IL-6, a multifunctional cytokine, controls diverse physiological processes including immune system. It shows functional redundancy with . In humans, the receptor for IL-6 is expressed throughout the menstrual cycle specifically localized in the glandular epithelium. Higher levels of IL-6 is found in the glandular and luminal epithelial cells during the mid-secretory phase, however, weak expression is evidenced in the proliferative phase [116, 117] . Therefore, a role in the human implantation could also be postulated for this cytokine. IL-6 is maximally expressed during the window of implantation and that its receptor is found both in the blastocyst and in the endometrium suggests a paracrine/autocrine role for IL-6 in the peri-implantation period. Deficiency of IL-6 leads to decrease in the number of viable implantation sites and thus affecting the outcome of pregnancy [118] . Experiments using mice with a targeted disruption in the IL-6 gene have shown that the development of blastocyst is compromised with no adverse effect on the blastocyst implantation [119, 120] . Based on the fact endometrial mRNA is suppressed in the mid-secretory phase of patients with recurrent abortions, the role of IL-6 during early pregnancy has been well established [121, 122] .
Interleukin-11 (IL-11)
IL-11 is a cytokine with pleiotropic activities on range of cell types. It was initially described as growth factor acting on multiple stages during hematopoiesis, synergizing with other factors [123] . IL-11 and its receptor (IL-11Rα) have recently been demonstrated in human endometrium. All the major cell types in endometrium express IL-11 with cyclical variation. The most prominent immunoreactivity and mRNA expression was observed in the decidualized stromal cells late in the menstrual cycle [124] [125] [126] . Strong immunoreactivity for IL-11Rα and gp130 was observed in both luminal and glandular epithelium [126, 127] . Mice lacking the IL-11Rα have a fertility defect because of defective decidualization and in normal uterus maximal level of IL-11 was observed at the time of decidualization [128] . Furthermore, IL-11
